Clinical Market Access FDA-cleared, low-cost, scalable sleep diagnostic and management solution that clinics and hospitals can deploy rapidly, enabling sleep apnea screening and diagnosis without traditional PSG; target opportunities include sleep centers, cardiology and pulmonary clinics, and integrated care programs.

Pediatric Growth Clearance for both adults and children ages two and up opens pediatric and family-health opportunities; pursue partnerships with pediatric clinics, ENT practices, and school-health programs to expand usage and drive adoption.

Research Partnerships Active collaboration with the Sleep Research Society creates entry points for academic medical centers and grant-funded studies; offer research collaborations, data analytics, and pilot programs to accelerate institutional procurement.

Home Telehealth Cloud-based SaMD with a finger sensor and mobile app enables remote data collection and home sleep testing, aligning with telehealth and home-health strategies; market to DME distributors, home-health providers, and employer-health programs.

Channel Strategy Small, cost-efficient platform positions SleepImage as a complementary option to larger players; pursue channel partnerships with sleep clinics, DME providers, and hospital systems seeking a lower-cost, flexible SaMD-based solution to augment sleep-diagnostic workflows.